Midatech is a pharmaceutical company with a focus on oncology and other therapeutic areas. It operates globally and has a US commercial arm that markets four cancer care supportive products, as well as co-promoting two others. The company's approach is to internally develop oncology products and work with partners for other therapy areas, with growth targeted both organically and through strategic acquisitions.